Sawai Pharmaceutical Co Ltd - Company Profile
Powered by
All the data and insights you need on Sawai Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Sawai Pharmaceutical Co Ltd Strategy Report
- Understand Sawai Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Sawai Pharmaceutical Co Ltd patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US11406600B2 | Grant | Anhydrous dasatinib-containing preparation | A61K31/506; A61K9/2813 | August 09, 2022 |
WO2022102457A1 | Application | LINAGLIPTIN-CONTAINING ORALLY DISINTEGRATING TABLET | A61K9/20; C07D473/06; A61K31/522; A61P3/10; A61K47/38; A61K47/36 | May 19, 2022 |
JP2022062674A | Application | SUSPENSION GRANULES AND GRANULE PREPARATIONS FOR SUSPENSION USING THE SAME | April 20, 2022 | |
US20220110865A1 | Application | METHOD FOR MANUFACTURING ORALLY DISINTEGRATING TABLET, AND ORALLY DISINTEGRATING TABLET | A61K9/0056; A61K9/2027; A61K9/205; A61K9/2054 | April 14, 2022 |
JP2022046449A | Application | GRANULES, PREPARATION INCLUDING GRANULES, METHOD FOR PRODUCING GRANULES, AND METHOD FOR PRODUCING PREPARATION INCLUDING GRANULES | March 23, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer